NASDAQ : MDCX

Medicus Pharma Ltd. — Company profile

Healthcare · Drug Manufacturers - General · United States

Last price 2.15 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.72M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Details

NameMedicus Pharma Ltd.
SectorHealthcare
IndustryDrug Manufacturers - General
Founded2008
CeoRaza Bokhari
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinCA58471K3010
Cusip58471K202
Cik1997296
Sic2834

Key executives

NameTitle
Dr. Raza Bokhari M.B.A., M.D.Chief Executive Officer and Executive Chairman
Dr. Edward J. Brennan Jr., F.A.C.S., M.D.Chief Scientific Officer and Head of Research & Development Program
Dr. Faisal Mehmud M.D.Chief Medical Officer
Andrew Alasdair SmithChief Operating Officer
Anna Baran-Djokovic J.D.Senior Vice President of Investor Relations
Viktoria SlepeniukSenior Vice President of Public Relations
Maryann AdessoChief of Staff and Corporate Secretary

Contact

Address300 Conshohocken State Road, Suite 200, West Conshohocken, Pennsylvania 19428, United States
Phone610 636 0184
Websitehttps://medicuspharma.com